Scientists can finally hear the brain's quietest messages—unlocking the hidden code behind how neurons think, decide, and remember.
Scientists have created a new protein that can capture the incoming chemical signals received by brain cells, not just the signals they send out. These incoming messages are carried by glutamate, a neurotransmitter that plays a central role in brain communication. Although glutamate activity is essential for how the brain functions, its signals are extremely subtle and fast, making them nearly impossible to observe until now.
This breakthrough allows researchers to record these faint chemical messages as they arrive at individual neurons, opening a new window into how the brain processes information.
Why this breakthrough matters
By detecting incoming signals, scientists can now explore how neurons actually compute information. Each neuron integrates thousands of inputs before producing an output, a process that underlies thinking, decision making, and memory. Being able to observe this process directly could help explain long-standing questions about how the brain works.
The discovery also has important implications for disease research. Abnormal glutamate signaling has been linked to conditions such as Alzheimer's disease, schizophrenia, autism, and epilepsy. Having tools that can track these signals more precisely may help researchers identify what goes wrong in these disorders.
Drug development could benefit as well. Pharmaceutical researchers can use these sensors to see how experimental treatments affect real synaptic activity, potentially speeding up the development of more effective therapies.

A new protein that listens to neurons
The protein, developed by scientists at the Allen Institute and HHMI's Janelia Research Campus, is a molecular "glutamate indicator" known as iGluSnFR4 (pronounced 'glue sniffer'). It is sensitive enough to detect the weakest incoming chemical signals exchanged between neurons.
By revealing when and where glutamate is released, iGluSnFR4 offers a new way to interpret the complex patterns of activity that support learning, memory, and emotion. Researchers can now observe neurons communicating inside the brain in real time, rather than inferring activity indirectly. The findings were recently published in Nature Methods and could significantly change how neural activity is measured and analyzed in neuroscience research.
How neurons communicate inside the brain
To appreciate the importance of this advance, it helps to understand how brain cells interact. Billions of neurons communicate by sending electrical pulses down long, branch-like structures called axons. When an electrical signal reaches the end of an axon, it cannot cross the tiny gap to the next cell, known as a synapse.
Instead, the signal triggers the release of chemical messengers called neurotransmitters into the synapse. Glutamate, the most common neurotransmitter in the brain, is especially important for memory, learning, and emotion. When glutamate reaches the next neuron, it can cause that cell to fire and pass the signal along.
This process resembles a chain reaction, but it is far more intricate. Each neuron receives input from thousands of others, and only specific combinations and patterns of those inputs determine whether the receiving neuron activates. With this new protein sensor, scientists can now identify which patterns of incoming signals lead to neuronal firing.

Capturing signals that were once invisible
Until now, observing these incoming signals in living brain tissue was nearly impossible. Earlier technologies were either too slow or not sensitive enough to measure activity at individual synapses. As a result, researchers could only see fragments of neural communication rather than the full exchange.
"It's like reading a book with all the words scrambled and not understanding the order of the words or how they're arranged," said Kaspar Podgorski, Ph.D., a lead author of the study and senior scientist at the Allen Institute. "I feel like what we're doing here is adding the connections between those neurons, and by doing that, we now understand the order of the words on the pages, and what they mean."
Before protein sensors like iGluSnFR4 existed, scientists were limited to recording outgoing signals from neurons. The incoming messages were too weak and brief to detect, leaving a major gap in understanding how brain cells communicate.

Filling a critical gap in neuroscience
"Neuroscientists have pretty good ways of measuring structural connections between neurons, and in separate experiments, we can measure what some of the neurons in the brain are saying, but we haven't been good at combining these two kinds of information. It's hard to measure what neurons are saying to which other neurons," Podgorski said. "What we have invented here is a way of measuring information that comes into neurons from different sources, and that's been a critical part missing from neuroscience research."
Jeremy Hasseman, Ph.D., a scientist at HHMI's Janelia Research Campus, emphasized the collaborative effort behind the discovery. "The success of iGluSnFR4 stems from our close collaboration started at HHMI's Janelia Research Campus between the GENIE Project team and Kaspar's lab. That research has extended to the phenomenal in vivo characterization work done by the Allen Institute's Neural Dynamics group," he said. "This was a great example of collaboration across labs and institutes to enable new discoveries in neuroscience."
Opening the door to new discoveries
This advance removes a major obstacle in modern neuroscience by making it possible to directly observe how brain cells receive information. With iGluSnFR4 now available to researchers through Addgene, scientists have a powerful new tool to explore how the brain functions at its most fundamental level. As this technology is adopted more widely, it may help uncover answers to some of the brain's most enduring mysteries.
Reference: "Glutamate indicators with increased sensitivity and tailored deactivation rates" 23 December 2025, Nature Methods.
DOI: 10.1038/s41592-025-02965-z
News
New method generates renewable supply of progenitor immune cells
In a paper published in Cell, a USC Stem Cell-led team reports a new way of generating a renewable and expandable supply of the progenitor cells that give rise to macrophages. These immune cells help [...]
Scientists Just Discovered a Cellular Survival System That Was Never Supposed To Exist
A surprising backup pathway allows cells to make a crucial amino acid when their primary machinery fails. For decades, biologists believed cells had only one way to access a molecule they cannot live without. New [...]
Artificial cells gain porous membranes, enabling lab reactions and drug release
Artificial cells created in the laboratory offer a wide range of potential applications. Until now, however, their membranes—unlike those of real cells—have been virtually impermeable. Researchers at the Max Planck Institute for Polymer Research, [...]
Popular Weight-Loss Drugs Like Ozempic Linked to Lower Breast Cancer Risk
Ozempic and similar weight-loss drugs were linked to a striking 30% reduction in breast cancer risk in a study of more than 110,000 women. Popular weight-loss and diabetes medications such as Ozempic, Wegovy, Mounjaro, [...]
Stanford Scientists Discover Explosive New Type of Immune Cell
Scientists studying the remarkable regenerative abilities of planarian flatworms have uncovered a previously unknown type of immune cell with an unusually destructive defense strategy. What if an immune cell could wipe out nearby threats [...]
Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
Bay Area biotech SonoThera is bubbling to a clinical boil after raising a $125 million series B with the backing of some of the biggest names in pharma. Vida Ventures led the raise, with the venture [...]
Joint initiative of 5 EU countries calls for ‘unified approach’ to pharma framework amid US drug pricing pressure
With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries is calling for a “unified approach” to strengthen Europe’s pharmaceutical framework and access to innovative medicines. Belgium, the Netherlands, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
New book from Nanoappsmedical Inc. – Global Health Care Equivalency
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
UCLA Scientists Uncover a “Hidden Weakness” in Some of the World’s Deadliest Cancers
A new study has uncovered an unexpected vulnerability in some of the deadliest cancers. Researchers at UCLA have identified a previously hidden weakness in some of the most aggressive cancers, pointing to a possible new way [...]
AI-designed universal coronavirus vaccine clears first human trial
Key Takeaways Super-Antigen Technology: Uses AI and machine learning to analyze viral genomes, creating a single vaccine that targets essential features across entire virus families, including coronaviruses and Ebola. Human Trials & Safety: Phase [...]
Researchers Discover a Hidden Vitamin D Problem That Persists Year-Round
A new study suggests that some groups may not experience the expected seasonal boost in vitamin D levels, even during the sunniest months of the year. Many people assume that spending more time outdoors [...]
Researchers Solve the Mystery Behind a Billion-Dollar Dental Implant Disease
Researchers have uncovered why a common and costly dental implant infection often resists antibiotics. Dental implants have helped tens of millions of people regain a full set of stable, functional teeth, something traditional dentures [...]
Nanoparticles inspired by lung fluid improve therapies targeting respiratory system
The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend of lipids and proteins that line the alveoli and enables breathing), which are encapsulated [...]















